Fluoro-substituted 3,4-diaryl-4,5-dihydro-1H-pyrazole-1-ca rboxamidine derivatives having CB1 antagonistic activity

Details for Australian Patent Application No. 2009268271 (hide)

Owner Abbott Healthcare Products B.V.

Inventors Vliet, Van Bernard J.; Lange, Josephus H.M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009268271

PCT Pub. Number WO2010/003760

Priority 61/061,716 16.06.08 US; 08158309.8 16.06.08 EP

Filing date 15 June 2009

Wipo publication date 14 January 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2010/003760 Priority application(s): WO2010/003760

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009268280-Ballistic resistant article comprising a plurality of multilayered material sheets

2009268250-Process and apparatus for manufacturing frozen aerated confections